Health Stoke Therapeutics Accelerates Enrollment and Data Readout for Dravet Syndrome Study Stoke Therapeutics, Inc., based in Bedford, Massachusetts, has announced significant updates regarding its ongoing clinical trial for zorevunersen, a potential treatment for Dravet syndrome.... Editorial11 January, 2026